机构:[1]Adrenal Center, Division of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[2]Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.[3]Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.[4]Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.[5]Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA.[6]Center for Adrenal Disorders, Brigham and Women's Hospital, Harvard Medical School, MA, USA.[7]Department of Surgery, Division of Endocrine and Oncologic Surgery, University of Pennsylvania, PA, USA.[8]Department of Endocrinology and Metabolism, Copenhagen University Hospital, Copenhagen, Denmark.[9]Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark.[10]Department of Endocrinology, Odense University Hospital, Denmark.[11]Department of Oncology-Pathology, Karolinska Institute, Solna, Sweden.[12]Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Solna, Sweden.[13]Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.[14]Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden.[15]Department of Medicine, Renal Division, University of Pennsylvania, PA, USA.[16]Unidade de Adrenal, Laboratório de Hormônios e Genética Molecular LIM/42, Serviço de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil.[17]Servico de Endocrinologia, Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil.[18]Division of Endocrinology, University of Colorado, Denver, CO, USA.[19]Department of Urology, Mayo Clinic, Rochester, MN, USA.
This research was partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the U.S. National Institutes of Health (NIH) under award K23DK121888 (to I.B.) and by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under award KL2 TR001879 (to H.W.). The views expressed are those of the author(s) and not necessarily those of the National Institutes of Health
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区医学
小类|2 区内分泌学与代谢
最新[2023]版:
大类|2 区医学
小类|2 区内分泌学与代谢
第一作者:
第一作者机构:[1]Adrenal Center, Division of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, China.[2]Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
通讯作者:
通讯机构:[2]Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.[*1]Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA
推荐引用方式(GB/T 7714):
Yu Kai,Ebbehøj Andreas Ladefoged,Obeid Hiba,et al.Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results from a Multi-center Study[J].The Journal of clinical endocrinology and metabolism.2022,doi:10.1210/clinem/dgac427.
APA:
Yu Kai,Ebbehøj Andreas Ladefoged,Obeid Hiba,Vaidya Anand,Else Tobias...&Bancos Irina.(2022).Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results from a Multi-center Study.The Journal of clinical endocrinology and metabolism,,
MLA:
Yu Kai,et al."Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results from a Multi-center Study".The Journal of clinical endocrinology and metabolism .(2022)